我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

西地那非治疗老年慢性心力衰竭并发肺动脉高压的效果

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第2期
页码:
185-188
栏目:
临床研究
出版日期:
2018-02-15

文章信息/Info

Title:
Efficacy of sildenafil in the treatment of elderly patients with chronic heart failure with pulmonary hypertension
作者:
李 骞; 叶伟祥; 张 强
(福建医科大学附属泉州第一医院老年病科，福建 泉州 362000)
Author(s):
LI Qian;  YE Wei-xiang;  ZHANG Qiang
(Department of Geriatrics, Quanzhou First Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China)
关键词:
老年; 心力衰竭; 慢性; 肺动脉高压; 西地那非
Keywords:
elderly;  heart failure;  chronic;  pulmonary hypertension;  sildenafil
分类号:
R541.61
DOI:
-
文献标识码:
A
摘要:
目的 观察西地那非治疗老年慢性心力衰竭（CHF）并发肺动脉高压（PH）的效果。方法 将86例老年CHF并PH患者随机分为两组:对照组和试药组（每组43例）。对照组采用常规治疗方法，试药组在此基础上使用西地那非治疗，比较两组患者的治疗效果、左心功能、肺动脉收缩压（PASP)、超敏C反应蛋白（hs-CRP）及氨基末端脑钠尿肽前体（NT-pro-BNP）水平。结果 试药组治疗后左室射血分数（LVEF)（42±11）%、左室短轴缩短率（LVFS）（26±7）%和6分钟步行距离（6MWT）（423±52）m，明显高于对照组的（39±8）%、（23±6）%和（361±32）m，差异均有统计学意义（均P<0.05）；试药组治疗后PASP（36±9）mmHg、hs-CRP（9±4）mg/L及NT-pro-BNP（535±49）ng/L均明显低于对照组的（40±8）mmHg、（13±4）mg/L和（796±97）ng/L，两组间差异显著（均P<0.05）。结论 西地那非治疗老年CHF并PH效果显著优于常规治疗。
Abstract:
AIM To observe the efficacy of sildenafil in the treatment of elderly patients with chronic heart failure with pulmonary hypertension. METHODS 86 elderly patients in our hospital with chronic heart failure with pulmonary hypertension were randomly divided into two groups. The control group was treated with conventional therapy and the treatment group was treated with sildenafil. Left ventricular function, pulmonary arterial systolic pressure (PASP), high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) were compared between the two groups. RESULTS Left ventricular ejection fraction (LVEF) (42±1)%, Left ventricular fractional shortening (LVFS) (26±7)%, and 6--minute walk test (6-MWT) (423±52) m in the treatment group, were significantly higher than the control group (39±8)%, (23±6)%, (361±32) m (P<0.05); The levels of PASP (36±9) mmHg, hs-CRP (9±4) mg/L and NT-pro-BNP (535±49) ng/L in the observation group were significantly lower than the control group (40±8) mmHg, (13±4) mg/L, (796±97) ng/L (P<0.05). CONCLUSION There are significant effects of sildenafil in the treatment of elderly patients with chronic heart failure with pulmonary hypertension and these effects are superior to conventional treatment.

参考文献/References

[1]Butler J,Chomsky DB,Wilson JR,et al.Pulmonary hypertension and exercise intolerance in patients with heart failure[J].J Am Coll Cardiol,1999,34(6):1802-1806.

[2]Damy T,Goode KM,Kallvikbacka BA,et al.Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure[J].Eur Heart J,2010,31(18):2280-2290.

[3]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.

[4]廉湘琳.左西孟旦联合西地那非治疗慢性心衰肺动脉高压的临床研究[D].郑州:郑州大学,2013:1-39.

[5]诸葛瑞琪,倪新海.左心疾病相关性肺动脉高压和药物治疗[J].中国心血管杂志,2016,21(2):165-170.

[6]杨京华,朱晨曦,王增智,等.贝前列素钠联合西地那非治疗肺动脉高压的临床观察[J].心肺血管病杂志,2014,33(6):816-818.

[7]王全政,秦 毅,沃金善.血浆NT-pro-BNP水平及肺动脉收缩压对慢性左心心力衰竭病人预后的预测价值[J].齐鲁医学杂志,2014,29(5):439-441.

[8]赵施皓,杨智伟,郑墟旸,等.microRNA在肺动脉高压形成中的作用[J].心脏杂志,2013,25(4):494-498.

[9]闫 芳，夏 宇，李 威,等.西地那非治疗肺动脉高压的疗效及安全性研究[J].中国临床药理学杂志,2014,30(10):877-879.

[10]Correale M,Totaro A,Ferraretti A,et al.Sildenafil improves clinical and functional status of an elderly postmenopausal female with 'out of proportion' PH associated with left heart disease[J].Monaldi Arch Chest Dis,2013,80(4):193-194.

[11]Aleixandre L,Cortell J,Vicente R,et al.Nitrid oxide, levosimendan and sildenafile in a patient with right ventricle dysfunction and severe pulmonary hypertension after cardiac surgery[J].Rev Esp Anestesiol Reanim,2014,61(9):513-516.

[12]殷晓明，胡晓荃，张金惠,等.老年慢性阻塞性肺病稳定期血浆前白蛋白、脑钠肽及C反应蛋白水平与肺动脉高压的相关性[J].中国老年学杂志,2013,33(20):5152-5153.

[13]Andersen MJ,Ersboll M,Axelsson A,et al.Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction:the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction(SIDAMI)trial[J].Circulation,2013,127(11):1200-1208.

备注/Memo

备注/Memo:
收稿日期：2017-05-25.作者简介：李骞，主治医生，硕士 Email：69790661@qq.com
更新日期/Last Update: 1900-01-01